cannabis investing Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference
cannabis investing Cardiol Therapeutics Announces Plans for Orphan Drug Program in Acute Myocarditis with CardiolRx CBD Formulation
cannabis investing Cardiol Therapeutics’ Pharmaceutical Partner Noramco Presents at U.S. FDA Public Hearing on CBD
pharmaceutical investing Cardiol Therapeutics: A Leader in Research and Commercial Development of Pharmaceutical Cannabidiol Products and Targeted Therapies for Heart Failure and Cancer
cannabis investing Cardiol Therapeutics Completes Initial Public Offering and the Company’s Common Shares and Warrants Commence Trading on the Toronto Stock Exchange Under the Symbols “CRDL” and “CRDL.WT”
Surface Metals Inc. Provides Corporate Update: Gold's 2025 Rally Amplifies Cimarron Gold Project Potential and Strengthens Strategic Position
Bold Ventures Provides Recent News at Koper Lake in the Ring of Fire and Burchell Gold and Copper Project
